In conclusion, the screening platform presented in this review represents an effective method for the identification of potential antidiabetic partial PPARγ agonists from complex extracts that can turn out to be lead compounds for developing drugs for the prevention and/or treatment of T2D. The gene discussed is PPARG; the disease is type 2 diabetes mellitus.